(Q44073105)

English

Pre-transplant positron emission tomography (PET) using fluorine-18-fluoro-deoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Pre-transplant positron emission tomography (PET) using fluorine-18-fluoro-deoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

positron emission tomography

1 reference

based on heuristic

inferred from title

author name string

Cremerius U

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Fabry U

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Wildberger JE

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Zimny M

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Reinartz P

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Nowak B

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Schaefer W

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Buell U

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Osieka R

9

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

0 references

publication date

1 July 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

103-111

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703607

0 references

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703607

21 January 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703607

21 January 2018

Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703607

21 January 2018

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703607

21 January 2018

World Health Organization Classification of lymphomas: a work in progress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703607

21 January 2018

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703607

21 January 2018

High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703607

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703607

21 January 2018

Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703607

21 January 2018

Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703607

7 January 2021

based on heuristic

inferred from DOI database lookup

Extranodal malignant lymphoma: detection with FDG PET versus CT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703607

7 January 2021

based on heuristic

inferred from DOI database lookup

Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703607

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of emission tomographic scan data: limitations imposed by resolution and background

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703607

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703607

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44073105&oldid=2106282997"